Ferring Research Institute Inc., San Diego
|
Snapshot |
Ferring Research Institute (FRI) was established in San Diego in 1996 as the company’s centre of excellence for peptide research located at the heart of Southern California’s biomedical community. FRI broadly applies its peptide know-how to create value both within and outside Ferring’s preferred therapeutic areas, thus often working with external partners. |
|
Location |
FRI, which is building a new, state-of-the-art research facility, is located in San Diego, at the heart of the Southern California’s biomedical community, the fastest-growing biopharmaceutical cluster in the United States. This location provides access to world leading academic institutions, biotechnology, medical devices, and pharmaceutical companies, venture capital firms and supportive trade organizations. |
|
R&D Focus |
FRI specialises in molecular target1 selection and drug discovery2 based on Ferring’s peptide technology and know-how. |
|
Employees |
FRI employs highly skilled biopharmaceutical scientists originating from all around the world and representing more than a dozen different countries, languages and cultures. Keeping with Ferring’s philosophy “people come first” -, FRI recognizes and values its scientist’s know-how and creativity. |
|
Speciality areas |
FRI focuses its research efforts on pathological pathways controlled by peptides and proteins, with the objective to design peptide-based, agonists and antagonists molecules, capable to specifically alter the pathological processes within a range of therapeutic areas. |
|
History |
|
Contact details
Ferring Research Institute Inc.
3550 General Atomics Ct.
Bldg. 2 Room 444
San Diego, CA 92121
USA
Phone: +1 858 455 3185
Fax: +1 858 455 3190
E-mail:
Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από κακόβουλη χρήση. Χρειάζεται να ενεργοποιήσετε την Javascript για να τη δείτε.